Data / Form D filings / resistanceBio, Inc.
resistanceBio, Inc.: Form D filing
resistanceBio, Inc., a pharmaceuticals company in Menlo Park, CA, filed a Form D with the SEC in 2024. The latest, on January 31, 2024, reports $12.8 million sold of a $12.8 million offering to 44 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 980 O'BRIEN DR, Menlo Park, CA, 94025
- Phone
- (925) 708-6165
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2010024
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | New notice | $12,776,288 | $12,776,288 | 44 | Jan 29, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| NICHOLAS GOLDNER | Executive Officer, Director | |
| KYLE LAPHAM | Executive Officer, Director | |
| OMRI AMIRAV-DRORY | Director | |
| CHRISTOPHER BULOW | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Jan 29, 2024 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what resistanceBio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.